A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture

Optimal treatment of cancer requires diagnostic methods to facilitate therapy choice and prevent ineffective treatments. Direct assessment of therapy response in viable tumor specimens could fill this diagnostic gap. Therefore, we designed a microfluidic platform for assessment of patient treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakrabarty, Sanjiban, Quiros-Solano, William F., Kuijten, Maayke M.P., Haspels, Ben, Mallya, Sandeep, Lo, Calvin Shun Yu, Othman, Amr, Silvestri, Cinzia, van de Stolpe, Anja, Gaio, Nikolas, Odijk, Hanny, van de Ven, Marieke, de Ridder, Corrina M.A., van Weerden, Wytske M., Jonkers, Jos, Dekker, Ronald, Taneja, Nitika, Kanaar, Roland, van Gent, Dik C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Convergence and Technologies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397621/
https://www.ncbi.nlm.nih.gov/pubmed/34872965
http://dx.doi.org/10.1158/0008-5472.CAN-21-0799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397621/
https://www.ncbi.nlm.nih.gov/pubmed/34872965
http://dx.doi.org/10.1158/0008-5472.CAN-21-0799

Ejemplares similares